Human Herpesvirus 6 (HHV-6) Antibody Testing
The HHV-6 antibody test detects antibodies that cannot distinguish between the two variants of HHV-6 (HHV-6A and HHV-6B) and is not recommended as the primary diagnostic method for active HHV-6 infection. 1, 2
Antibody Testing Characteristics
HHV-6 antibody tests detect:
- IgG antibodies - indicate past or current infection
- IgM antibodies - theoretically indicate recent infection, but have limitations
Key limitations of antibody testing:
- Cannot differentiate between HHV-6A and HHV-6B variants 2, 1
- IgM detection is a poor indicator of recent infection (approximately one-third of patients with recurrent genital herpes caused by HSV-2 have IgM responses) 2
- May reflect cross-reactivity with other herpesviruses, particularly CMV 1
- Not reliable in immunocompromised patients 1
Diagnostic Value and Recommendations
- Antibody testing is not indicated in hematopoietic stem cell transplant (HSCT) patients 2
- Elevated HHV-6 antibody titers alone have limited clinical significance 1
- Four-fold or greater increase in anti-HHV-6 antibody titers between acute and convalescent serum samples may indicate active infection 1
- IgM anti-HHV-6 detection in infants and young children may indicate active infection 1
Preferred Diagnostic Methods
Quantitative PCR is the mainstay of HHV-6 diagnosis and should:
Detection in cell-free plasma suggests active viral replication with the following threshold values:
- Whole Blood: >5.5 log10 copies/mL
- Serum: 100-fold lower than whole blood 1
Special Considerations
In cases of suspected chromosomally integrated HHV-6 (CIHHV-6):
For encephalitis diagnosis:
Clinical Pitfalls to Avoid
- Do not rely solely on antibody testing for diagnosis of active HHV-6 infection
- Do not use IgM detection alone to confirm recent infection
- Do not assume that positive HHV-6 antibody results indicate the cause of current symptoms
- Remember that antibody avidity testing may help distinguish between primary and recurrent infection in some cases 3